Showing 1 - 20 results of 37 for search 'Teresa Caballero', query time: 0.07s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
Safety, effectiveness, and impact on quality of life of self-administration with plasma-derived nanofiltered C1 inhibitor (Berinert®) in patients with hereditary angioedema: the SA... by Andrea Zanichelli, Giulia Maria Azin, Federico Cristina, Romualdo Vacchini, Teresa Caballero
Published 2018-04-01
Article -
7
-
8
Advent of oral medications for the treatment of hereditary angioedema by Anna Valerieva, Teresa Caballero, Markus Magerl, Joao P. Frade, Paul K. Audhya, Timothy Craig
Published 2024-09-01
Article -
9
Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study by Teresa Caballero, Andrea Zanichelli, Werner Aberer, Marcus Maurer, Hilary J. Longhurst, Laurence Bouillet, Irmgard Andresen, the IOS Study Group
Published 2018-03-01
Article -
10
Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report by Konrad Bork, John T. Anderson, Teresa Caballero, Timothy Craig, Douglas T. Johnston, H. Henry Li, Hilary J. Longhurst, Cristine Radojicic, Marc A. Riedl
Published 2021-04-01
Article -
11
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. by Marcus Maurer, Werner Aberer, Laurence Bouillet, Teresa Caballero, Vincent Fabien, Gisèle Kanny, Allen Kaplan, Hilary Longhurst, Andrea Zanichelli, I O S Investigators
Published 2013-01-01
Article -
12
Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey by Anette Bygum, Teresa Caballero, Anete S. Grumach, Hilary J. Longhurst, Laurence Bouillet, Werner Aberer, Andrea Zanichelli, Jaco Botha, Irmgard Andresen, Marcus Maurer, for the IOS Study Group
Published 2019-07-01
Article -
13
The complexities of decision-making associated with on-demand treatment of hereditary angioedema (HAE) attacks by Stephen D. Betschel, Teresa Caballero, Douglas H. Jones, Hilary J. Longhurst, Michael Manning, Sally van Kooten, Markus Heckmann, Sherry Danese, Ledia Goga, Autumn Ford Burnette
Published 2024-07-01
Article -
14
Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey by Andrea Zanichelli, Markus Magerl, Hilary J. Longhurst, Werner Aberer, Teresa Caballero, Laurence Bouillet, Anette Bygum, Anete S. Grumach, Jaco Botha, Irmgard Andresen, Marcus Maurer, the IOS Study Group
Published 2018-10-01
Article -
15
Hereditary angioedema: quality of life in Brazilian patients by Maria Abadia Consuelo M. S. Gomide, Eliana Toledo, Solange Oliveira Rodrigues Valle, Regis A. Campos, Alfeu T. França, Nieves Prior Gomez, Heitor Franco Andrade Jr., Teresa Caballero, Anete S. Grumach
Published 2013-01-01
Article -
16
Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leuke... by Estefanía García-Guerrero, Luís I. Sánchez-Abarca, Esther Domingo, Teresa L. Ramos, Jose A. Bejarano-García, Jose A. Gonzalez-Campos, Teresa Caballero-Velázquez, Jose A. Pérez-Simón
Published 2018-09-01
Article -
17
A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain by Néboa Zozaya, Teresa Caballero, Teresa González-Quevedo, Pedro Gamboa Setien, M. Ángeles González, Ramón Jódar, José Luis Poveda-Andrés, Encarna Guillén-Navarro, Agustín Rivero Cuadrado, Álvaro Hidalgo-Vega
Published 2022-01-01
Article -
18
Microbiome and Allergic Diseases by Mariona Pascal, Marina Perez-Gordo, Marina Perez-Gordo, Teresa Caballero, Maria M. Escribese, M. Natividad Lopez Longo, Olga Luengo, Luis Manso, Victor Matheu, Elena Seoane, Miguel Zamorano, Moisés Labrador, Cristobalina Mayorga
Published 2018-07-01
Article -
19
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation by Teresa Caballero-Velázquez, Luis Ignacio Sánchez-Abarca, Silvia Gutierrez-Cosio, Belén Blanco, Cristina Calderon, Carmen Herrero, Soraya Carrancio, Concepción Serrano, Consuelo del Cañizo, Jesús F. San Miguel, José A. Pérez-Simón
Published 2012-09-01
Article -
20
ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia‐related changes and normal karyotype by Concepción Prats‐Martín, Sergio Burillo‐Sanz, Rosario M. Morales‐Camacho, Olga Pérez‐López, Milagros Suito, Maria T. Vargas, Teresa Caballero‐Velázquez, Estrella Carrillo‐Cruz, José González, Ricardo Bernal, José A. Pérez‐Simón
Published 2020-06-01
Article